NCT00373503View on ClinicalTrials.gov

Effect of Lofexidine and Oral THC on Marijuana Withdrawal and Relapse

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

June 30, 2007

Study Completion Date

September 30, 2008

Conditions
Marijuana Dependence
Interventions
DRUG

Lofexidine

alpha 2 adrenergic agonist, hypothesized to decrease noradrenergic activity

DRUG

dronabinol

cannabinoid agonist hypothesized to decrease MJ withdrawal

DRUG

Marijuana

marijuana intoxication, withdrawal and relapse assessed

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT00373503 - Effect of Lofexidine and Oral THC on Marijuana Withdrawal and Relapse | Biotech Hunter | Biotech Hunter